User profiles for Yasushi Yatabe
Y. YATABEVerified email at ncc.go.jp Cited by 74563 |
[HTML][HTML] International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of …
…, AG Nicholson, KR Geisinger, Y Yatabe… - Journal of thoracic …, 2011 - Elsevier
Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …
Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer: Biological and Clinical Implications
T Kosaka, Y Yatabe, H Endoh, H Kuwano, T Takahashi… - Cancer research, 2004 - AACR
Recently it has been reported that mutations in the tyrosine kinase domain of the epidermal
growth factor receptor(EGFR) gene occur in a subset of patients with lung cancer showing a …
growth factor receptor(EGFR) gene occur in a subset of patients with lung cancer showing a …
Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non–small-cell lung cancer with …
…, M Shinoda, T Takahashi, Y Yatabe - Journal of Clinical …, 2005 - ascopubs.org
Purpose To evaluate the relationship between mutations of the epidermal growth factor
receptor (EGFR) gene and the effectiveness of gefitinib treatment in patients with recurrent lung …
receptor (EGFR) gene and the effectiveness of gefitinib treatment in patients with recurrent lung …
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an …
T Mitsudomi, S Morita, Y Yatabe, S Negoro… - The lancet …, 2010 - thelancet.com
Background Patients with non-small-cell lung cancer harbouring mutations in the epidermal
growth factor receptor (EGFR) gene respond well to the EGFR-specific tyrosine kinase …
growth factor receptor (EGFR) gene respond well to the EGFR-specific tyrosine kinase …
Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival
…, S Tomida, H Osada, H Endoh, T Harano, Y Yatabe… - Cancer research, 2004 - AACR
In this study, we report for the first time reduced expression of the let-7 microRNA in human
lung cancers. Interestingly, 143 lung cancer cases that had undergone potentially curative …
lung cancers. Interestingly, 143 lung cancer cases that had undergone potentially curative …
Comprehensive genomic profiles of small cell lung cancer
We have sequenced the genomes of 110 small cell lung cancers (SCLC), one of the deadliest
human cancers. In nearly all the tumours analysed we found bi-allelic inactivation of TP53 …
human cancers. In nearly all the tumours analysed we found bi-allelic inactivation of TP53 …
Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib
T Kosaka, Y Yatabe, H Endoh, K Yoshida, T Hida… - Clinical Cancer …, 2006 - AACR
Purpose: Non–small cell lung cancers carrying activating mutations in the gene for the
epidermal growth factor receptor (EGFR) are highly sensitive to EGFR-specific tyrosine kinase …
epidermal growth factor receptor (EGFR) are highly sensitive to EGFR-specific tyrosine kinase …
[HTML][HTML] The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification
The 2015 World Health Organization (WHO) Classification of Tumors of the Lung, Pleura,
Thymus and Heart has just been published with numerous important changes from the 2004 …
Thymus and Heart has just been published with numerous important changes from the 2004 …
A Polycistronic MicroRNA Cluster, miR-17-92, Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation
…, H Yamada, K Yanagisawa, S Tomida, Y Yatabe… - Cancer research, 2005 - AACR
MicroRNAs (miRNAs) are small noncoding RNAs, thought to be involved in physiologic and
developmental processes by negatively regulating expression of target genes. We have …
developmental processes by negatively regulating expression of target genes. We have …
[HTML][HTML] EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors
…, J Takashima, T Nakajima, Y Yatabe… - … England Journal of …, 2010 - Mass Medical Soc
<p id="p001">The EML4 (echinoderm microtubule-associated protein-like 4)–ALK (anaplastic
lymphoma kinase) fusion-type tyrosine kinase is an oncoprotein found in 4 to 5% of non–…
lymphoma kinase) fusion-type tyrosine kinase is an oncoprotein found in 4 to 5% of non–…